These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 4040949

  • 21. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 22. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
    Kitajima T, Mochizuki M, Nishimura R.
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
    [Abstract] [Full Text] [Related]

  • 23. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY, Saxena BB, Landesman R.
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [Abstract] [Full Text] [Related]

  • 24. Application of the radioreceptor assay for human chorionic gonadotropin in pregnancy testing and management of trophoblastic disease.
    Boyko WL, Russell HT.
    Obstet Gynecol; 1977 Sep; 50(3):324-32. PubMed ID: 197458
    [Abstract] [Full Text] [Related]

  • 25. Cytological distribution of chorionic gonadotropin subunit and placental lactogen messenger RNA in neoplasms derived from human placenta.
    Hoshina M, Hussa R, Pattillo R, Boime I.
    J Cell Biol; 1983 Oct; 97(4):1200-6. PubMed ID: 6619191
    [Abstract] [Full Text] [Related]

  • 26. Structural differences found in the asparagine-linked sugar chains of human chorionic gonadotropins purified from the urine of patients with invasive mole and with choriocarcinoma.
    Endo T, Nishimura R, Kawano T, Mochizuki M, Kobata A.
    Cancer Res; 1987 Oct 01; 47(19):5242-5. PubMed ID: 2957051
    [Abstract] [Full Text] [Related]

  • 27. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
    Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E.
    Obstet Gynecol; 2004 Sep 01; 104(3):551-4. PubMed ID: 15339768
    [Abstract] [Full Text] [Related]

  • 28. The thyrotropin in hydatidiform moles is human chorionic gonadotropin.
    Kenimer JG, Hershman JM, Higgins HP.
    J Clin Endocrinol Metab; 1975 Mar 01; 40(3):482-91. PubMed ID: 1167868
    [Abstract] [Full Text] [Related]

  • 29. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
    Shimizu T, Matsuura S, Mochizuki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct 01; 35(10):1759-66. PubMed ID: 6195275
    [Abstract] [Full Text] [Related]

  • 30. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI.
    Gynecol Oncol; 2002 May 01; 85(2):315-20. PubMed ID: 11972394
    [Abstract] [Full Text] [Related]

  • 31. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
    Levavi H, Neri A, Bar J, Regev D, Nordenberg J, Ovadia J.
    Obstet Gynecol; 1993 Oct 01; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
    [Abstract] [Full Text] [Related]

  • 32. Differences in current clinical features of diploid and triploid hydatidiform mole.
    Niemann I, Petersen LK, Hansen ES, Sunde L.
    BJOG; 2007 Oct 01; 114(10):1273-7. PubMed ID: 17655732
    [Abstract] [Full Text] [Related]

  • 33. The molar vesicle fluid contains the beta-core fragment of human chorionic gonadotropin.
    Khan S, Katabuchi H, Araki M, Ohba T, Koizumi T, Okamura H, Nishimura R.
    Placenta; 2000 Jan 01; 21(1):79-87. PubMed ID: 10692255
    [Abstract] [Full Text] [Related]

  • 34. The clinicopathologic profile of the partial hydatidiform mole.
    Szulman AE, Surti U.
    Obstet Gynecol; 1982 May 01; 59(5):597-602. PubMed ID: 7070731
    [Abstract] [Full Text] [Related]

  • 35. Serum human chorionic somatomammotropin in unaborted hydatidiform mole.
    Dawood MY, Teoh ES.
    Obstet Gynecol; 1976 Feb 01; 47(2):183-8. PubMed ID: 1250540
    [Abstract] [Full Text] [Related]

  • 36. [The excretion of chorionic gonadetropin in 55 cases of hydatidiform mole (author's transl)].
    Lichtenegger W, Weiss PA.
    Geburtshilfe Frauenheilkd; 1977 Apr 01; 37(4):334-7. PubMed ID: 192629
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [On the results of hydatidiform mole managed by Niigata method].
    Hando T, Kodama S, Takeuchi S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec 01; 37(12):2722-30. PubMed ID: 4086902
    [Abstract] [Full Text] [Related]

  • 39. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar 01; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

  • 40. Comparison of carbohydrate structure between human chorionic gonadotropin present in urine of patients with trophoblastic diseases and healthy individuals.
    Mizuochi T, Nishimura R, Taniguchi T, Utsunomiya T, Mochizuki M, Derappe C, Kobata A.
    Jpn J Cancer Res; 1985 Aug 01; 76(8):752-9. PubMed ID: 3930453
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.